BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 28745318)

  • 1. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
    Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
    Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
    Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R
    Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
    Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
    Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism.
    Lu YX; Yuan L; Xue XL; Zhou M; Liu Y; Zhang C; Li JP; Zheng L; Hong M; Li XN
    Clin Cancer Res; 2014 May; 20(10):2631-42. PubMed ID: 24658157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
    Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
    Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine downregulates microRNA-200c to promote metastasis and the epithelial-mesenchymal transition in human colorectal cancer cells.
    Lei Z; Xiaomin Y; He H; Jian C; Xiaowu X
    J Cell Physiol; 2019 Feb; 234(2):1369-1379. PubMed ID: 30076725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
    Karimi Dermani F; Saidijam M; Amini R; Mahdavinezhad A; Heydari K; Najafi R
    J Cell Biochem; 2017 Jun; 118(6):1547-1555. PubMed ID: 27918105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of miR-200c in colon cancer and associated molecular mechanisms.
    Chen J; Wang W; Zhang Y; Hu T; Chen Y
    Tumour Biol; 2014 Jul; 35(7):6475-83. PubMed ID: 24682933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.
    Rajabi H; Alam M; Takahashi H; Kharbanda A; Guha M; Ahmad R; Kufe D
    Oncogene; 2014 Mar; 33(13):1680-9. PubMed ID: 23584475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
    Wang L; Yu P
    Oncol Rep; 2016 Dec; 36(6):3225-3232. PubMed ID: 27779716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
    Rokavec M; Bouznad N; Hermeking H
    Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
    Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X
    RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effects of lncRNA ATB targeting miR-200c on proliferation and apoptosis of colorectal cancer cells.
    Gao Z; Zhou H; Wang Y; Chen J; Ou Y
    J Cell Biochem; 2020 Jan; 121(1):332-343. PubMed ID: 31222825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.
    Shi X; Kaller M; Rokavec M; Kirchner T; Horst D; Hermeking H
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):391-418. PubMed ID: 32304779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
    Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
    Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
    Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
    Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.